EG20072A - Therapeutic compounds - Google Patents

Therapeutic compounds

Info

Publication number
EG20072A
EG20072A EG54292A EG54292A EG20072A EG 20072 A EG20072 A EG 20072A EG 54292 A EG54292 A EG 54292A EG 54292 A EG54292 A EG 54292A EG 20072 A EG20072 A EG 20072A
Authority
EG
Egypt
Prior art keywords
pct
alkyl
image
sec
optionally substituted
Prior art date
Application number
EG54292A
Other languages
English (en)
Original Assignee
Pfizer Inc Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc Limited filed Critical Pfizer Inc Limited
Application granted granted Critical
Publication of EG20072A publication Critical patent/EG20072A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EG54292A 1991-09-14 1992-09-14 Therapeutic compounds EG20072A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919119705A GB9119705D0 (en) 1991-09-14 1991-09-14 Therapeutic compounds

Publications (1)

Publication Number Publication Date
EG20072A true EG20072A (en) 1999-06-30

Family

ID=10701448

Family Applications (1)

Application Number Title Priority Date Filing Date
EG54292A EG20072A (en) 1991-09-14 1992-09-14 Therapeutic compounds

Country Status (31)

Country Link
US (1) US5543419A (ja)
EP (1) EP0603229B1 (ja)
JP (2) JP2672030B2 (ja)
KR (1) KR0135784B1 (ja)
CN (1) CN1037269C (ja)
AT (1) ATE167187T1 (ja)
AU (1) AU659487B2 (ja)
BR (1) BR9206499A (ja)
CA (1) CA2116356C (ja)
CZ (1) CZ281752B6 (ja)
DE (1) DE69225897T2 (ja)
DK (1) DK0603229T3 (ja)
EG (1) EG20072A (ja)
ES (1) ES2116343T3 (ja)
FI (1) FI114707B (ja)
GB (1) GB9119705D0 (ja)
GR (1) GR3027667T3 (ja)
HU (1) HU220594B1 (ja)
IL (1) IL103078A (ja)
MX (1) MX9205221A (ja)
MY (1) MY108602A (ja)
NO (1) NO305397B1 (ja)
NZ (1) NZ244324A (ja)
PL (1) PL170627B1 (ja)
PT (1) PT100863B (ja)
RU (1) RU2117669C1 (ja)
SG (1) SG50414A1 (ja)
TW (1) TW251285B (ja)
UA (1) UA42686C2 (ja)
WO (1) WO1993006098A1 (ja)
ZA (1) ZA926939B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0785198B1 (de) 1996-01-19 2000-07-05 Lonza Ag Verfahren zur Herstellung von optisch aktivem 3-Chinuclidinol
CZ54498A3 (cs) * 1997-03-07 1998-11-11 Lonza Ag Katalyzátorová směs na bázi amorfního částečně dehydratovaného hydroxidu zirkoničitého a způsob její výroby a použití
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
US6060454A (en) * 1997-08-08 2000-05-09 Duke University Compositions, apparatus and methods for facilitating surgical procedures
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
JP4445704B2 (ja) 2000-12-22 2010-04-07 アルミラル・ソシエダッド・アノニマ キヌクリジンカルバメート誘導体およびｍ３アンダゴニストとしてのそれらの使用
UA75626C2 (en) 2000-12-28 2006-05-15 Almirall Prodesfarma Ag Quinuclidine derivatives and medicinal compositions containing the same
DE102004057995A1 (de) * 2004-12-01 2006-06-08 Wacker Chemie Ag Verfahren zur Herstellung von α,α-Dialkyl-α-Hydroxymethyl-Carbonsäurederivaten
US20100112061A1 (en) * 2006-12-13 2010-05-06 William Baker Monophosphates as Mutual Prodrugs of Muscarinic Receptor Antagonists and Beta-Agonists for the Treatment of COPD And Chronic Bronchitis
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843074A (en) * 1988-05-17 1989-06-27 Marion Laboratories, Inc. 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
GB8923590D0 (en) * 1989-10-19 1989-12-06 Pfizer Ltd Antimuscarinic bronchodilators

Also Published As

Publication number Publication date
NO305397B1 (no) 1999-05-25
TW251285B (ja) 1995-07-11
GB9119705D0 (en) 1991-10-30
DE69225897D1 (de) 1998-07-16
FI114707B (fi) 2004-12-15
IL103078A0 (en) 1993-02-21
HU9400729D0 (en) 1994-06-28
WO1993006098A1 (en) 1993-04-01
EP0603229B1 (en) 1998-06-10
HUT66772A (en) 1994-12-28
ES2116343T3 (es) 1998-07-16
PT100863B (pt) 1999-07-30
US5543419A (en) 1996-08-06
JP2672030B2 (ja) 1997-11-05
HU220594B1 (hu) 2002-03-28
SG50414A1 (en) 1998-07-20
JPH06510991A (ja) 1994-12-08
JP2955533B2 (ja) 1999-10-04
CN1070911A (zh) 1993-04-14
FI941170A0 (fi) 1994-03-11
DE69225897T2 (de) 1998-10-15
ATE167187T1 (de) 1998-06-15
AU2482392A (en) 1993-04-27
EP0603229A1 (en) 1994-06-29
CN1037269C (zh) 1998-02-04
CA2116356A1 (en) 1993-04-01
CZ395392A3 (en) 1994-07-13
NO940905D0 (no) 1994-03-14
JPH09315970A (ja) 1997-12-09
RU2117669C1 (ru) 1998-08-20
AU659487B2 (en) 1995-05-18
DK0603229T3 (da) 1998-10-12
IL103078A (en) 1996-07-23
PL170627B1 (en) 1997-01-31
BR9206499A (pt) 1995-11-21
KR0135784B1 (ko) 1998-04-23
CZ281752B6 (cs) 1997-01-15
FI941170A (fi) 1994-03-11
UA42686C2 (uk) 2001-11-15
NO940905L (no) 1994-03-14
PT100863A (pt) 1993-10-29
MX9205221A (es) 1993-03-01
ZA926939B (en) 1994-03-11
GR3027667T3 (en) 1998-11-30
MY108602A (en) 1996-10-31
CA2116356C (en) 1998-03-31
NZ244324A (en) 1993-12-23

Similar Documents

Publication Publication Date Title
EG20072A (en) Therapeutic compounds
GB9524157D0 (en) Therapeutic agents
GR3034769T3 (en) Triazole antifungal agents.
ATE185555T1 (de) Monoamin oxydase b hemmende verbidungen verfahren zu ihrer herstellung un ihrer verwendung
ZA929914B (en) Therapeutic agents.
GB9314562D0 (en) Use of cephem derivatives as anti-metastatic agents
PL308754A1 (en) Therapeutic agents